SCHEMBL16163186

SCHEMBL16163186

CCOC(=O)C1(C)Nc2ccc(OC)cc2C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
L3MBTL1 Q9Y468 4/20 0.43
KDM4E B2RXH2 6/20 0.43
HPGD P15428 5/20 0.43
HIF1A Q16665 2/20 0.43
GLA P06280 1/20 0.43
LMNA P02545 3/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ALOX12 P18054 2/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16170243 0.85 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDHIF1ALMNA
SCHEMBL17179169 0.81 ALDH1A1 (0.51) ALDH1A1L3MBTL1KDM4EHPGDGLA
SCHEMBL16163080 0.76 ALDH1A1 (0.50) ALDH1A1L3MBTL1KDM4EHPGDHIF1A
SCHEMBL16163180 0.75 ALDH1A1 (0.56) ALDH1A1L3MBTL1KDM4EHPGDHIF1A
SCHEMBL16163474 0.72 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDLMNACA1
SCHEMBL16170238 0.72 KDM4E (0.32) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL23618091 0.71 SMN1; SMN2 (0.44) ALDH1A1L3MBTL1KDM4EHPGDLMNA
SCHEMBL29042896 0.71 ALDH1A1 (0.50) ALDH1A1L3MBTL1KDM4EHPGDHIF1A
SCHEMBL11539506 0.70 ALDH1A1 (0.57) ALDH1A1L3MBTL1KDM4EHPGDHIF1A
SCHEMBL16163092 0.70 ALDH1A1 (0.49) ALDH1A1L3MBTL1KDM4EHPGDHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9145364-B2 Synthesis of psuedo indoxyl derivatives COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-09-29 US disclosed
US-9145364-B2 Synthesis of psuedo indoxyl derivatives COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-09-29 US disclosed
US-20140309434-A1 SYNTHESIS OF PSUEDO INDOXYL DERIVATIVES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-10-16 US disclosed
US-20140309434-A1 SYNTHESIS OF PSUEDO INDOXYL DERIVATIVES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309434-A1 SYNTHESIS OF PSUEDO INDOXYL DERIVATIVES IPO4, IPO11, IDO2 ALDH1A1 2135/4885L3MBTL1 4839/4885KDM4E 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.